Mirum Pharmaceuticals CEO Christopher Peetz's 2020 pay falls 52% to $3M

Mirum Pharmaceuticals reports 2020 executive compensation

By ExecPay News

Published: April 14, 2021

Mirum Pharmaceuticals reported fiscal year 2020 executive compensation information on April 14, 2021.
In 2020, three executives at Mirum Pharmaceuticals received on average a compensation package of $2.3M, a 62% decrease compared to previous year.
Average pay of disclosed executives at Mirum Pharmaceuticals
Christopher Peetz, Chief Executive Officer, received $3M in total, which decreased by 52% compared to 2019. 74% of Peetz's compensation, or $2.2M, was in option awards. Peetz also received $266K in bonus, $512K in salary, as well as $7.5K in other compensation.
Peter Radovich, Chief Operating Officer, received a compensation package of $2.6M. 85% of the compensation package, or $2.3M, was in option awards.
Ian Clements, Chief Financial Officer, earned $1.4M in 2020.

Related executives

Christopher Peetz

Mirum Pharmaceuticals

Chief Executive Officer

Peter Radovich

Mirum Pharmaceuticals

Chief Operating Officer

Ian Clements

Mirum Pharmaceuticals

Chief Financial Officer

You may also like

Source: SEC filing on April 14, 2021.